Outcomes with liquid biopsy to determine the EGFR mutation status in poor performance status, biopsy-ineligible, advanced NSCLC patients

Background: Outcomes based on liquid biopsy in poor performance, older, biopsy-ineligible advanced non-small cell lung cancer (NSCLC) patients are unknown. Aim: The aim of the study was to evaluate the outcomes of patients treated on the basis of liquid biopsy to determine the epidermal growth facto...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Avinash Pandey, Sarjana Dutt, Anjana Singh, Amit Kumar, Shivkant Singh
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wolters Kluwer Medknow Publications 2019-01-01
Edice:	Cancer Research, Statistics, and Treatment
Témata:	cfdna ctdna epidermal growth factor receptor non-small cell lung cancer poor performance status
On-line přístup:	http://www.crstonline.com/article.asp?issn=2590-3233;year=2019;volume=2;issue=2;spage=197;epage=203;aulast=Pandey
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!